Making pediatric cancer more 'visible' boosts immunotherapy response
High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous system. While a newer class of targeted immunotherapy drugs has improved survival rates, according ...
Oct 5, 2026
0
5









